Education
About Us
Working with TipRanks
Follow Us
Cue Biopharma Inc (CUE)
NASDAQ:CUE
| Dec 25 | Mar 25 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 27.47M | $ 9.29M | $ 5.49M | $ 1.25M | $ 14.94M |
| Gross Profit | $ 23.99M | $ 9.29M | $ -32.61M | $ 1.25M | $ 16.72M |
| Operating Income | $ -26.55M | $ -41.50M | $ -52.15M | $ -53.23M | $ -43.71M |
| EBITDA | $ -23.04M | $ -37.53M | $ -46.05M | $ -50.49M | $ -45.44M |
| Net Income | $ -26.60M | $ -40.67M | $ -50.73M | $ -53.01M | $ -44.16M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 27.14M | $ 23.39M | $ 48.51M | $ 76.29M | $ 64.37M |
| Total Assets | $ 42.21M | $ 32.19M | $ 61.53M | $ 91.28M | $ 83.40M |
| Total Debt | $ 4.20M | $ 8.88M | $ 14.70M | $ 19.32M | $ 12.02M |
| Net Debt | $ -22.94M | $ -13.58M | $ -33.82M | $ -32.30M | $ -52.35M |
| Total Liabilities | $ 15.78M | $ 14.69M | $ 24.45M | $ 25.60M | $ 17.91M |
| Stockholders' Equity | $ 26.43M | $ 17.50M | $ 37.09M | $ 65.68M | $ 65.49M |
| Cash Flow | |||||
| Free Cash Flow | $ -21.86M | $ -36.40M | $ -39.96M | $ -41.98M | $ -39.75M |
| Operating Cash Flow | $ -21.69M | $ -36.33M | $ -39.96M | $ -41.81M | $ -38.84M |
| Investing Cash Flow | $ 75.00K | $ 32.00K | $ 25.00M | $ -24.61M | $ 9.11M |
| Financing Cash Flow | $ 26.29M | $ 10.24M | $ 11.86M | $ 53.66M | $ 19.23M |